Evidence map›Paper›PMID 31595174›Full record

ArticleFrontiers in immunology

Corrigendum: Interleukin 33/ST2 Axis Components Are Associated to Desmoplasia, a Metastasis-Related Factor in Colorectal Cancer.

Glauben Landskron, Marjorie De la Fuente López, Karen Dubois-Camacho, David Díaz-Jiménez, Octavio Orellana-Serradell, Diego Romero, Santiago A Sepúlveda, Christian Salazar, Daniela Parada-Venegas, Rodrigo Quera and 11 more

Abstract readPublished Erratum
In one paragraph

Article in Frontiers in immunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Glauben LandskronImmunology Program, Innate Immunity Laboratory, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.
Marjorie De la Fuente LópezImmunology Program, Innate Immunity Laboratory, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.
Karen Dubois-CamachoImmunology Program, Innate Immunity Laboratory, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.
David Díaz-JiménezImmunology Program, Innate Immunity Laboratory, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.
Octavio Orellana-SerradellImmunology Program, Innate Immunity Laboratory, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.
Diego RomeroPathology Department, Faculty of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Santiago A SepúlvedaPathology Department, Faculty of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Christian SalazarImmunology Program, Innate Immunity Laboratory, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.
Daniela Parada-VenegasImmunology Program, Innate Immunity Laboratory, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.
Rodrigo QueraInflammatory Bowel Disease Program, Gastroenterology Department, Clinica Las Condes, Santiago, Chile.
Daniela SimianResearch Sub-direction, Academic Direction, Clinica Las Condes, Santiago, Chile.
María-Julieta GonzálezCell and Molecular Biology Program, Faculty of Medicine, Institute of Biomedical Sciences, Universidad de Chile, Santiago, Chile.
Francisco López-KöstnerColoproctology Department, Clinica Las Condes, Santiago, Chile.
Udo KronbergColoproctology Department, Clinica Las Condes, Santiago, Chile.
Mario AbedrapoColoproctology Department, Clinica Las Condes, Santiago, Chile.
Iván GallegosPathology Department, Hospital Clinico Universidad de Chile, Santiago, Chile.
Héctor R ContrerasDepartment of Basic and Clinic Oncology, Faculty of Medicine, Universidad de Chile, Santiago, Chile.
Cristina PeñaMedical Oncology Department, Ramon y Cajal University Hospital, IRYCIS, CIBERONC, Madrid, Spain.
Guillermo Díaz-ArayaMolecular Pharmacology Laboratory, Faculty of Chemical Pharmaceutical Sciences, Universidad de Chile, Santiago, Chile.
Juan Carlos RoaPathology Department, Faculty of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Marcela A HermosoImmunology Program, Innate Immunity Laboratory, Faculty of Medicine, Biomedical Sciences Institute, Universidad de Chile, Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2019.01394.].

Indexed as

cancer associated fibroblastscolorectal cancerdesmoplasiaepithelial-mesenchymal transitioninterleukin 33

Identifiers

PMID31595174
PMCPMC6769820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.